½Ã°£ |
´ë°´ç |
Á¦1¼¼¹Ì³ª½Ç |
Á¦2¼¼¹Ì³ª½Ç |
¼Ò°ÀÇ½Ç |
09:00-10:20 |
PS1. Sleep and
Neurodegeneration |
ÁÂÀå : ±èÁÖÇÑ (ÇѾçÀÇ´ë),
ÃÖ¼öÀü (ÀÎÁ¦ÀÇ´ë) |
|
PS2. Genetics in sleep disorder |
ÁÂÀå : ½Åö (°í·ÁÀÇ´ë),
ÀÌÇâ¿î (ÀÌÈÀÇ´ë) |
|
OP 1. Consequences of OSA |
ÁÂÀå : Á¤À¯»ï (¿ï»êÀÇ´ë),
±èÁöÇö (´Ü±¹ÀÇ´ë) |
|
|
1) Sleep and normal aging |
±èÅ (¼¿ïÀÇ´ë Á¤½Å°Ç°ÀÇÇаú) |
|
1) Genetics in Circadian rhythm
disorder |
ÀÌÁ¤Èñ (°¿øÀÇ´ë Á¤½Å°Ç°ÀÇÇаú) |
|
|
2) Sleep and dementia |
¹è°æ¿ (Àü³²ÀÇ´ë Á¤½Å°Ç°ÀÇÇаú) |
|
2) Genetics in RLS and PLM |
±è¸í±Ô (Àü³²ÀÇ´ë ½Å°æ°ú) |
|
|
3) Sleep and Parkinson' disease |
õ»ó¸í (µ¿¾ÆÀÇ´ë ½Å°æ°ú) |
|
3) Genetics in sleep apnea |
³ªÁø¿À (°í·ÁÀÇ´ë ¼øȯ±â³»°ú) |
|
|
4) Sleep and stroke |
±è´ë¿µ (Ãæ³²ÀÇ´ë ½Å°æ°ú) |
|
4) Genetics in Narcolepsy |
È«½Âö (°¡Å縯ÀÇ´ë Á¤½Å°Ç°ÀÇÇаú) |
|
|
10:20-10:35 |
Coffee break and poster viewing |
10:35-10:40 |
°³È¸½Ä |
|
|
10:40-11:05 |
Invited Lecture (English) |
ÁÂÀå : ÀÌÁ¤Èñ (2015 WASM °øµ¿Á¶Á÷À§¿øÀå, °¿øÀÇ´ë) |
|
|
|
Technician Course : ¼ö¸é
Àå¾Ö Áø´ÜÀåºñ¿Í Ä¡·áÀåºñ¿¡
´ëÇÑ ÀÌÇØ¿Í Àû¿ë |
Epidemiology of insomnia:
Current findings and future
challenges |
YK Wing (Hong Kong) |
|
|
|
TS1. ¼ö¸éÀå¾Ö Áø´ÜÀåºñ¿¡ ´ëÇÑ ÀÌÇØ (10:40-12:20, 100 min) |
ÁÂÀå : ¾ç±¤ÀÍ (¼øõÇâÀÇ´ë),
±è¹Î¼º (»ï¼º¼¿ïº´¿ø) |
|
11:05-12:10 |
Plenary symposium : Cardiovascular Consequence of OSA (English) |
ÁÂÀå : ÀÌÀç¼ (´ëÇѼö¸éÇÐȸÀå,
¼¿ïÀÇ´ë) |
|
|
|
1) ¼ö¸éÀå¾Ö Áø´ÜÀåºñ ¼Ò°³ |
¾ç±¤ÀÍ (¼øõÇâÀÇ´ë ½Å°æ°ú) |
|
1) Cardiovascular consequences
of sleep apnea |
C Shin (Korea) |
|
|
|
2) ¼ö¸é´Ù¿ø°Ë»ç ¼¾¼¿¡ ´ëÇÑ ÀÌÇØ |
±¸´ë¸² (¼¿ïÀÇ´ë ½Å°æ°ú) |
|
2) Cardiovascular consequences
in sleep apnea, what can we
learn from sleep disorders
other than sleep apnea? |
F Han (China) |
|
|
|
3) ÈÞ´ë¿ë°Ë»çÀåºñ(portable
monitoring device)ÀÇ ÀÌÇØ |
ÃÖÁöÈ£ (°í·ÁÀÇ´ë À̺ñÀÎÈÄ°ú) |
|
3) The longterm outcome and
neurocognitive consequence of pediatric
OSA after adenotonsillectomy |
YS Huang (Taiwan) |
|
|
|
4) È°µ¿ÃøÁ¤±â(Actigraphy)ÀÇ ÀÌÇØ |
ÇѼ±Á¤ (¿ø±¤ÀÇ´ë ½Å°æ°ú) |
|
12:10-13:10 |
Lunch |
|
Luncheon Symposium :
Interesting case discussion |
ÁÂÀå : ½Å¿øö (°æÈñÀÇ´ë),
±èÁöÇö (´Ü±¹ÀÇ´ë), ÀÌÁ¤¼® (¼¿ïÀÇ´ë),
Á¶¼öÇö (°æÈñÀÇ´ë) |
|
|
´ëÇѼö¸éÇÐȸ ÆòÀ§¿øȸ |
13:10-14:30 |
PS3. OSA across lifespan |
ÁÂÀå : ÃÖ¼öÀü (ÀÎÁ¦ÀÇ´ë)
±¸¼ö±Ç (ºÎ»ê¼º¸ðº´¿ø)
|
|
PS4. Treatment update of RLS
and
PLM |
ÁÂÀå : Á¶¿ë¿ø (°è¸íÀÇ´ë),
³²Çö¿ì (¼¿ïÀÇ´ë) |
|
OP 2. Pathophysiology of OSA |
ÁÂÀå : À̽ÂÈÆ (°í·ÁÀÇ´ë),
À±Ã¢È£ (¼¿ïÀÇ´ë) |
|
OP3. Treatment of OSA |
ÁÂÀå : ±èÈ¿¿ (¼º±Õ°üÀÇ´ë),
Á¶ÀçÈÆ (°Ç±¹ÀÇ´ë) |
|
1) OSA in pediatrics and
adolescent |
ä±Ô¿µ (ºÐ´çÂ÷º´¿ø ¼Ò¾Æû¼Ò³â°ú) |
|
1) Advances in Iron treatment: Role of iron in RLS |
Á¶¿ë¿ø (°è¸íÀÇ´ë ½Å°æ°ú) |
|
|
|
2) OSA in adult |
¹ÚÂù¼ø (°¡Å縯ÀÇ´ë À̺ñÀÎÈÄ°ú) |
|
2) non-dopaminergic
medication in RLS |
À±Àοµ (¼¿ïÀÇ´ë Á¤½Å°Ç°ÀÇÇаú) |
|
|
3) OSA in elderly |
Á¤À¯»ï (¿ï»êÀÇ´ë À̺ñÀÎÈÄ°ú) |
|
3) Dopaminergic medication of
RLS |
Á¤±â¿µ (°í·ÁÀÇ´ë ½Å°æ°ú) |
|
|
4) OSA in women |
ÀÌÇâ¿î (ÀÌÈÀÇ´ë ½Å°æ°ú) |
|
4) Treatment of PLM |
½Å¿øö (°æÈñÀÇ´ë ½Å°æ°ú) |
|
|
14:30-14:50 |
Coffee break and poster viewing |
14:50-16:10 |
PS 5. Choice of treatment
modalities in OSA patient :
Panel discussion |
ÁÂÀå : ±è¼º¿Ï (°æÈñÀÇ´ë) |
|
PS6. Consequences of insomnia |
ÁÂÀå : È«½Âö (°¡Å縯ÀÇ´ë),
¿°È£±â (ÀÎÁ¦ÀÇ´ë) |
|
OP 4. Sleep physiology and parasomnias |
ÁÂÀå : À±Àοµ (¼¿ïÀÇ´ë),
ÇÑÇöÁ¤ (°üµ¿ÀÇ´ë) |
|
TS2. ¼ö¸éÀå¾Ö Ä¡·áÀåºñ¿¡ ´ëÇÑ ÀÌÇØ (14:30-16:10, 100 min) |
ÁÂÀå : È«ÀÏÈñ (¼¿ï¼ö¸é¼¾ÅÍ),
±èõ½Ä (¼¿ï¾Æ»êº´¿ø ³ú½Å°æ°Ë»ç½Ç) |
|
1) indication of PAP therapy
in OSA (10 min) |
±èÈÄ¿ø (Á¶¼±ÀÇ´ë ½Å°æ°ú) |
|
1) Cognitive dysfunction in
insomnia |
ÀÌ»óµ· (±¹±º¼öµµº´¿ø
Á¤½Å°Ç°ÀÇÇаú) |
|
|
1) ¼ö¸éÀå¾Ö Ä¡·áÀåºñ ¼Ò°³ |
È«ÀÏÈñ (¼¿ï¼ö¸é¼¾ÅÍ À̺ñÀÎÈÄ°ú) |
|
2) indication of surgery in
OSA (10 min) |
À̽ÂÈÆ (°í·ÁÀÇ´ë À̺ñÀÎÈÄ°ú) |
|
2) Brain structural
abnormalities in insomnia |
±èÁöÇö (°í·ÁÀÇ´ë ½Å°æ°ú) |
|
|
2) ¾Ó¾ÐÄ¡·á±âÀÇ ÀÌÇØ: CPAP, APAP, BiPAP |
½Åö (°í·ÁÀÇ´ë È£Èí±â³»°ú) |
|
3) Indication of dental device
in OSA ( 10 min) |
±è¼ºÅà (¿¬¼¼Ä¡´ë ±¸°³»°ú) |
|
3) Psychiatric morbidity
(depression and suicidality)
in insomnia |
¼¼ö¿¬ (°í·ÁÀÇ´ë Àΰ£À¯Àüü¿¬±¸¼Ò) |
|
|
3) PAP Interface trouble
shooting : mask,
humidification, leakage |
±èÁöÇö (´Ü±¹ÀÇ´ë ½Å°æ°ú) |
|
panel discussion (50 min) |
ÆгΠÅäÀÇ |
|
4) Cardiometabolic
derangement in insomnia |
±è¼¼Áß (¼¿ïÀÇ´ë È£Èí±â³»°ú) |
|
|
4) ±¸°³»ÀåÄ¡ÀÇ ÀÌÇØ |
±ÇÁ¤½Â (¿¬¼¼Ä¡´ë ±¸°³»°ú) |
|
16:15-17:35 |
PS7. Update of non-PAP
Treatment in OSA |
ÁÂÀå : Çã°æ (¿¬¼¼ÀÇ´ë),
±è¸í¸³ (¼¿ïÀϸ®³ëÀÌÄ¡°ú) |
|
PS8. Sleep related Paroxymal
movement : Video presentation |
ÁÂÀå : ÀÌ»ó¾Ï (¿ï»êÀÇ´ë),
±èÁö¾ð (´ë±¸°¡Å縯ÀÇ´ë) |
|
PS9. Update of chronic insomnia |
ÁÂÀå : À±Áø»ó (Àü³²ÀÇ´ë),
À±Àοµ (¼¿ïÀÇ´ë) |
|
|
1) Recent evidence of weight
control and positional therapy ? |
±è±¤±â (µ¿±¹ÀÇ´ë ½Å°æ°ú) |
|
1) Introduction of sleep related
paroxysmal movement (10 min) |
ÀÌ»ó¾Ï (¿ï»êÀÇ´ë ½Å°æ°ú) |
|
1) Update of diagnosis and
risk in chronic insomnia |
±è¿øÁÖ (¿¬¼¼ÀÇ´ë ½Å°æ°ú) |
|
2) Proper indications and
limitations of oral appliance |
Á¤Áø¿ì (¼¿ïÄ¡´ë ±¸°³»°ú) |
|
2) NREM related parasomnia |
°¼®ÈÆ (º¸Èƺ´¿ø Á¤½Å°Ç°ÀÇÇаú) |
|
2) Update of Pharmacological
treatment in chronic insomnia |
Á¤±ÔÀÎ (°¡Å縯ÀÇ´ë Á¤½Å°Ç°ÀÇÇаú) |
|
3) Clinical efficacy of upper
airway surgery |
±èÈ¿¿ (¼º±Õ°üÀÇ´ë À̺ñÀÎÈÄ°ú) |
|
3) REM related parasomnia |
Á¶Àç¿í (ºÎ»êÀÇ´ë ½Å°æ°ú) |
|
3) Update of Cognitive
behavioral therapy application
in chronic
insomnia |
±èÅ¿ø (°¡Å縯ÀÇ´ë Á¤½Å°Ç°ÀÇÇаú) |
|
4) Clinical application of
hypopharyngeal nerve stimulation |
±èÁ¤ÈÆ (¼¿ïÀÇ´ë À̺ñÀÎÈÄ°ú) |
|
4) Other Nocturnal paroxysmal movement |
¼Õ¿µ¹Î (°¡Å縯ÀÇ´ë ½Å°æ°ú) |
|
|
17:35-18:00 |
ÃÑȸ ¹× ½Ã»ó |
|
|